Back to search
Motor Neuron Disease, Familial
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Motor Neuron Disease, Familial trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Motor Neuron Disease, Familial trials you may qualify forThe goal of this clinical trial is to evaluate whether psilocybin therapy can effectively treat depression and psychological distress in adult patients with COP…
Pre-fALS is a prospective natural history and biomarker study of people not yet affected with ALS, but who are at genetic risk for developing ALS. The investiga…
The aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological…
This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron…
Amyotrophic lateral sclerosis (ALS) is a serious rapidly progressive disease of the nervous system. The average survival from the time of diagnosis is two to th…
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…
The primary purpose of this study is to evaluate the safety and tolerability of VRG50635 in participants with ALS.
The purpose of this study is to evaluate the safety, tolerability, PK, and PD of AP-101 in participants with fALS and sALS.
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approa…